In this file photo taken on August 28, 2019 the entry sign to the Johnson & Johnson campus shows their logo in Irvine, California. – Four drugmakers, including Johnson & Johnson, went on trial April 19, 2021, over claims they helped fuel the deadly opioid epidemic in the United States through deceptive marketing that downplayed the risks of addiction.
But the company will continue a parallel trial involving men who have sex with men and transgender individuals that is taking place in the Americas and Europe, where vaccine composition differs and so do the prevalent HIV strains. The J&J vaccine uses similar adenovirus technology to its Covid-19 vaccine, and was delivered with four vaccinations over a year.